Interpace Biosciences Inc Shares outstanding
What is the Shares outstanding of Interpace Biosciences Inc?
The Shares outstanding of Interpace Biosciences Inc is 4.388M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with shares outstanding similar to Interpace Biosciences Inc
- Franklin Services has Shares outstanding of 4.387M
- Franklin Services has Shares outstanding of 4.387M
- Franklin Services has Shares outstanding of 4.387M
- Franklin Services has Shares outstanding of 4.387M
- Franklin Services has Shares outstanding of 4.387M
- Franklin Services has Shares outstanding of 4.387M
- Interpace Biosciences Inc has Shares outstanding of 4.388M
- Nuveen Preferred and Income Fund has Shares outstanding of 4.392M
- Voith Paper Fabrics India has Shares outstanding of 4.393M
- Blue Cap AG has Shares outstanding of 4.396M
- Meraki Acquisition One has Shares outstanding of 4.400M
- Samurai Capital has Shares outstanding of 4.400M
- Mexico Equity And Income Fund Inc has Shares outstanding of 4.400M